8-KThe WireStrategic
Results of Operations
Filed May 6, 2026 · 2mo ago · Accession 0001193125-26-208975
Plain English
Tenaya Therapeutics, Inc. reported its financial results for the quarter ended March 31, 2026, and provided business updates on May 06, 2026. The report includes details on clinical trial progress, preclinical data, and a research collaboration.
Filing details
- Company
- Tenaya Therapeutics, Inc.
- Ticker
- TNYA
- CIK
- 1858848
- Form type
- 8-K
- Filing date
- May 6, 2026
- Report date
- May 6, 2026
- Document
- tnya-20260506.htm
- Size
- 308 KB